Tajima, H., Ohta, T., Okazaki, M., Yamaguchi, T., Ohbatake, Y., Okamoto, K., . . . Nakamura, H. (2019). Neoadjuvant chemotherapy with gemcitabine-based regimens improves the prognosis of node positive resectable pancreatic head cancer. Mol Clin Oncol.
Citação norma ChicagoTajima, Hidehiro, et al. "Neoadjuvant Chemotherapy With Gemcitabine-based Regimens Improves the Prognosis of Node Positive Resectable Pancreatic Head Cancer." Mol Clin Oncol 2019.
Citação norma MLATajima, Hidehiro, et al. "Neoadjuvant Chemotherapy With Gemcitabine-based Regimens Improves the Prognosis of Node Positive Resectable Pancreatic Head Cancer." Mol Clin Oncol 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.